Månsson-Brahme E - Search Results

1

[Unexpected telephone call informed about malignant melanoma].

Brandberg Y, Bolund C, Månsson-Brahme E, Ringborg U, Sjödén PO. Brandberg Y, et al. Lakartidningen. 1991 Sep 4;88(36):2907-9. Lakartidningen. 1991. PMID: 1895845 Swedish. No abstract available.

2

[Dysplastic nevi--precursors of malignant melanoma?].

Ringborg U, Broberg M, Lagerlöf B, Månsson-Brahme E. Ringborg U, et al. Lakartidningen. 1987 Aug 19;84(34):2587-9. Lakartidningen. 1987. PMID: 3669807 Swedish. No abstract available.

3

Information to patients with malignant melanoma: a randomized group study.

Brandberg Y, Bergenmar M, Bolund C, Michelson H, Månsson-Brahme E, Ringborg U, Sjödén PO. Brandberg Y, et al. Patient Educ Couns. 1994 Jun;23(2):97-105. doi: 10.1016/0738-3991(94)90047-7. Patient Educ Couns. 1994. PMID: 21207908 Clinical Trial.

4

Psychological reactions in patients with malignant melanoma.

Brandberg Y, Månsson-Brahme E, Ringborg U, Sjödén PO. Brandberg Y, et al. Eur J Cancer. 1995;31A(2):157-62. doi: 10.1016/0959-8049(94)00333-z. Eur J Cancer. 1995. PMID: 7718319

5

Psychological effects of participation in a prevention programme for individuals with increased risk for malignant melanoma.

Brandberg Y, Bergenmar M, Bolund C, Månsson-Brahme E, Ringborg U, Sjødén PO. Brandberg Y, et al. Eur J Cancer. 1992;28A(8-9):1334-8. doi: 10.1016/0959-8049(92)90512-z. Eur J Cancer. 1992. PMID: 1515245

6

Psychological reactions in public melanoma screening.

Brandberg Y, Bolund C, Michelson H, Månsson-Brahme E, Ringborg U, Sjödén PO. Brandberg Y, et al. Eur J Cancer. 1993;29A(6):860-3. doi: 10.1016/s0959-8049(05)80425-3. Eur J Cancer. 1993. PMID: 8484978

7

Six-month follow-up of effects of an information programme for patients with malignant melanoma.

Brandberg Y, Bergenmar M, Michelson H, Månsson-Brahme E, Sjödén PO. Brandberg Y, et al. Patient Educ Couns. 1996 Jul;28(2):201-8. doi: 10.1016/0738-3991(96)00894-4. Patient Educ Couns. 1996. PMID: 8852095 Clinical Trial.

8

Perceived susceptibility to and knowledge of malignant melanoma: screening participants vs the general population.

Brandberg Y, Bolund C, Michelson H, Mansson-Brahme E, Ringborg U, Sjödén PO. Brandberg Y, et al. Prev Med. 1996 Mar-Apr;25(2):170-7. doi: 10.1006/pmed.1996.0043. Prev Med. 1996. PMID: 8860282

9

Screening for cutaneous malignant melanoma: a feasibility study.

Törnberg S, Månsson-Brahme E, Lindén D, Ringborg U, Krakau I, Kärnell R, Landegren J, Brandberg Y, Hakulinen T. Törnberg S, et al. J Med Screen. 1996;3(4):211-5. doi: 10.1177/096914139600300411. J Med Screen. 1996. PMID: 9041488 Clinical Trial.

10

Trends in mortality from malignant melanoma in Sweden, 1970-1996.

Cohn-Cedermark G, Månsson-Brahme E, Rutqvist LE, Larsson O, Johansson H, Ringborg U. Cohn-Cedermark G, et al. Cancer. 2000 Jul 15;89(2):348-55. doi: 10.1002/1097-0142(20000715)89:2<348::aid-cncr20>3.0.co;2-x. Cancer. 2000. PMID: 10918165

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters